Search
Login
Our partners
We want to thank the following partners for supporting the Osteoporosis Conference 2023. Find out more about them and their involvement in the conference below.
Gold partners
UCB
A global biopharma company, inspired by the needs of people living with severe diseases. UCB’s ambition is to transform the lives of people living with severe diseases, allowing them to live the best life that they can – as free as possible from the challenges and uncertainty of disease. That commitment comes to life in our research and development activities across neurology, immunology and other areas where our expertise, innovation and ambition align with unmet needs.
Don’t miss the UCB symposium at 12.15 on Wednesday 13 September
AMGEN
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Don’t miss the Amgen symposium at 08.45 on Thursday 14 September
Silver partner
Stada UK – Thornton and Ross Ltd
We are one of the UK's fastest-growing, leading producers of household pharmaceutical products, and own some of the country's most loved brands such as Covonia®, Hedrin®, Cetraben® as well as the leading disinfectant Zoflora®. Many people in the UK will have a product from Thornton & Ross somewhere at home. We are also a trusted and reliable provider of prescription products, including emollients bone health products and generics, to the NHS with almost 100 years’ heritage behind us.
Don’t miss the Thornton & Ross symposium at 17.45 on Wednesday 13 September
Bronze partner
Flynn Pharma Ltd
Flynn Pharma is a privately held pharmaceutical company focused on primary care, secondary care and speciality medicine. We are engaged in a wide range of therapy areas including psychiatry, paediatrics, post-operative pain management, anti-infective medicine, women’s health, and emergency medicine. We introduce new products, improve existing formulations or add new indications to benefit patients. In everything we do, we endeavour to place patients at the centre of our thinking and efforts.
